These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antigen-specific active immunotherapy for ovarian cancer. Paijens ST; Leffers N; Daemen T; Helfrich W; Boezen HM; Cohlen BJ; Melief CJ; de Bruyn M; Nijman HW Cochrane Database Syst Rev; 2018 Sep; 9(9):CD007287. PubMed ID: 30199097 [TBL] [Abstract][Full Text] [Related]
4. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Gluud LL; Vilstrup H; Morgan MY Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Winter-Roach BA; Kitchener HC; Dickinson HO Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239 [TBL] [Abstract][Full Text] [Related]
6. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding. Tan YH; Lethaby A Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875 [TBL] [Abstract][Full Text] [Related]
13. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease. Khanna R; Preiss JC; MacDonald JK; Timmer A Cochrane Database Syst Rev; 2015 May; (5):CD007572. PubMed ID: 25942580 [TBL] [Abstract][Full Text] [Related]
14. Natalizumab for induction of remission in Crohn's disease. MacDonald JK; McDonald JW Cochrane Database Syst Rev; 2007 Jan; (1):CD006097. PubMed ID: 17253580 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment. Clarke T; Galaal K; Bryant A; Naik R Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD006119. PubMed ID: 25198378 [TBL] [Abstract][Full Text] [Related]
16. The use of monoclonal antibodies for the treatment of epithelial ovarian cancer (review). Oei AL; Sweep FC; Thomas CM; Boerman OC; Massuger LF Int J Oncol; 2008 Jun; 32(6):1145-57. PubMed ID: 18497976 [TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of ovarian cancer with antibodies: a focus on oregovomab. Berek JS Expert Opin Biol Ther; 2004 Jul; 4(7):1159-65. PubMed ID: 15268682 [TBL] [Abstract][Full Text] [Related]
18. Laparoscopy versus laparotomy for FIGO Stage I ovarian cancer. Medeiros LR; Rosa DD; Bozzetti MC; Rosa MI; Edelweiss MI; Stein AT; Zelmanowicz A; Ethur AB; Zanini RR Cochrane Database Syst Rev; 2008 Oct; (4):CD005344. PubMed ID: 18843688 [TBL] [Abstract][Full Text] [Related]
20. A phase I trial of idiotypic vaccination with HMFG1 in ovarian cancer. Nicholson S; Bomphray CC; Thomas H; McIndoe A; Barton D; Gore M; George AJ Cancer Immunol Immunother; 2004 Sep; 53(9):809-16. PubMed ID: 15127236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]